Skip to main content

Table 1 Descriptive analyses final cohort (N = 86)

From: Diagnostic performance of salivary urea nitrogen dipstick to detect and monitor acute kidney disease in patients with malaria

Variable Value
Age (years) 21.5 ± 9.5
Male (N; %) 61 (71%)
Presence of kidney disease (N; %) 27 (32%)
BUN at day 1 (mg/dL) 39.5 ± 14.9
sCr at day 1 (mg/dL) 5.38 ± 5.42
KDIGO—AKI stage 1 (N; %) 8 (29.7%)
KDIGO—AKI stage 2 (N; %) 4 (14.8%)
KDIGO—AKI stage 3 (N; %) 3 (11.1%)
AKD no AKI (N; %) 12 (44.4%)
  1. KDIGO classification: (a) AKI stage 1: variation of 1.5–1.9 times baseline serum creatinine OR ≥ 0.3 mg/dL (≥ 26.5 mmol/L) increase; (b) AKI stage 2: variation of 2.0–2.9 times baseline serum creatinine; (c) AKI stage 3: variation of 3.0 times baseline serum creatinine OR increase in serum creatinine to ≥ 4.0 mg/dL (≥ 353.6 mmol/L) OR initiation of renal replacement therapy OR, in patients < 18 years, decrease in eGFR to < 35 mL/min per 1.73 m2
  2. BUN blood urea nitrogen, sCR serum creatinine